Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Breast Cancer

  Free Subscription


13.05.2019

1 AJR Am J Roentgenol
1 Am J Surg
3 Ann Oncol
4 Ann Surg Oncol
1 BMC Cancer
1 Breast Cancer Res
8 Breast Cancer Res Treat
3 Breast J
1 Cancer Chemother Pharmacol
1 Cancer Res
1 Carcinogenesis
1 Clin Breast Cancer
3 Clin Cancer Res
2 Clin Exp Metastasis
1 Curr Treat Options Oncol
2 Eur J Cancer
1 Eur J Surg Oncol
1 Int J Radiat Oncol Biol Phys
1 J Clin Oncol
1 J Natl Cancer Inst
1 N Engl J Med
1 Nat Rev Clin Oncol
2 Oncogene
1 Oncol Rep
1 Oncology
6 PLoS One
1 Proc Natl Acad Sci U S A
2 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. ULANER GA
    PET/CT for Patients With Breast Cancer: Where Is the Clinical Impact?
    AJR Am J Roentgenol. 2019 May 7:1-12. doi: 10.2214/AJR.19.21177.
    PubMed     Text format     Abstract available


    Am J Surg

  2. JAY M, Creelman B, Baliski C
    Patient reported outcomes associated with surgical intervention for breast cancer.
    Am J Surg. 2019 Apr 17. pii: S0002-9610(18)31307.
    PubMed     Text format     Abstract available


    Ann Oncol

  3. MARSDEN J, Hamoda H
    European cancer mortality predictions for the year 2019 with focus on breast cancer, by Malvezzi M et al. (Ann Oncol 2019; 30: doi.org/10.1093/annonc/mdz051).
    Ann Oncol. 2019 May 9. pii: 5482565. doi: 10.1093.
    PubMed     Text format    

  4. MALVEZZI M, Carioli G, Bertuccio P, Boffetta P, et al
    Reply to the Letter to the Editor: "European cancer mortality predictions for the year 2019 with focus on breast cancer, by Malvezzi M et al." by J. Marsden, H. Hamoda, On behalf of the British Menopause Society Medical Advisory Council.
    Ann Oncol. 2019 May 9. pii: 5487409. doi: 10.1093.
    PubMed     Text format    

  5. PASCUAL J, Turner NC
    Targeting the PI3-kinase pathway in triple negative breast cancer.
    Ann Oncol. 2019 May 3. pii: 5485241. doi: 10.1093.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  6. RIDNER SH, Dietrich MS, Cowher MS, Taback B, et al
    A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement for the Prevention of Lymphedema Following Treatment for Breast Cancer: Interim Analysis.
    Ann Surg Oncol. 2019 May 3. pii: 10.1245/s10434-019-07344.
    PubMed     Text format     Abstract available

  7. JUNG SY, Han JH, Park SJ, Lee EG, et al
    The Sentinel Lymph Node Biopsy Using Indocyanine Green Fluorescence Plus Radioisotope Method Compared With the Radioisotope-Only Method for Breast Cancer Patients After Neoadjuvant Chemotherapy: A Prospective, Randomized, Open-Label, Single-Center Pha
    Ann Surg Oncol. 2019 May 7. pii: 10.1245/s10434-019-07400.
    PubMed     Text format     Abstract available

  8. RETROUVEY H, Kerrebijn I, Metcalfe KA, O'Neill AC, et al
    Psychosocial Functioning in Women with Early Breast Cancer Treated with Breast Surgery With or Without Immediate Breast Reconstruction.
    Ann Surg Oncol. 2019 May 6. pii: 10.1245/s10434-019-07251.
    PubMed     Text format     Abstract available

  9. SAUDER CAM
    ASO Author Reflections: Surgical Treatment for Male Breast Cancer in the Modern Era.
    Ann Surg Oncol. 2019 May 9. pii: 10.1245/s10434-019-07359.
    PubMed     Text format    


    BMC Cancer

  10. SUAREZ-KELLY LP, Pasley WH, Clayton EJ, Povoski SP, et al
    Effect of topical microporous polysaccharide hemospheres on the duration and amount of fluid drainage following mastectomy: a prospective randomized clinical trial.
    BMC Cancer. 2019;19:99.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  11. PROVANCE OK, Lewis-Wambi J
    Deciphering the role of interferon alpha signaling and microenvironment crosstalk in inflammatory breast cancer.
    Breast Cancer Res. 2019;21:59.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  12. AARTS BM, Klompenhouwer EG, Dresen RC, Laenen A, et al
    Intra-arterial Mitomycin C infusion in a large cohort of advanced liver metastatic breast cancer patients: safety, efficacy and factors influencing survival.
    Breast Cancer Res Treat. 2019 May 7. pii: 10.1007/s10549-019-05254.
    PubMed     Text format     Abstract available

  13. IRENE SU H, Stark S, Kwan B, Boles S, et al
    Efficacy of a web-based women's health survivorship care plan for young breast cancer survivors: a randomized controlled trial.
    Breast Cancer Res Treat. 2019 May 3. pii: 10.1007/s10549-019-05260.
    PubMed     Text format     Abstract available

  14. COHEN EN, Fouad TM, Lee BN, Arun BK, et al
    Elevated serum levels of sialyl Lewis X (sLe(X)) and inflammatory mediators in patients with breast cancer.
    Breast Cancer Res Treat. 2019 May 3. pii: 10.1007/s10549-019-05258.
    PubMed     Text format     Abstract available

  15. CAZZANIGA ME, Danesi R, Girmenia C, Invernizzi P, et al
    Management of toxicities associated with targeted therapies for HR-positive metastatic breast cancer: a multidisciplinary approach is the key to success.
    Breast Cancer Res Treat. 2019 May 7. pii: 10.1007/s10549-019-05261.
    PubMed     Text format     Abstract available

  16. LUX MP, Bohme S, Hucherig S, Jeratsch U, et al
    Surrogate threshold effect based on a meta-analysis for the predictive value of progression-free survival for overall survival in hormone receptor-positive, HER2-negative metastatic breast cancer.
    Breast Cancer Res Treat. 2019 May 7. pii: 10.1007/s10549-019-05262.
    PubMed     Text format     Abstract available

  17. FONTAINE C, Renard V, Van den Bulk H, Vuylsteke P, et al
    Weekly carboplatin plus neoadjuvant anthracycline-taxane-based regimen in early triple-negative breast cancer: a prospective phase II trial by the Breast Cancer Task Force of the Belgian Society of Medical Oncology (BSMO).
    Breast Cancer Res Treat. 2019 May 8. pii: 10.1007/s10549-019-05259.
    PubMed     Text format     Abstract available

  18. MORI H, Kubo M, Kai M, Yamada M, et al
    T-bet(+) lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancer.
    Breast Cancer Res Treat. 2019 May 8. pii: 10.1007/s10549-019-05256.
    PubMed     Text format     Abstract available

  19. AZRAD M, Blair CK, Rock CL, Sedjo RL, et al
    Adult weight gain accelerates the onset of breast cancer.
    Breast Cancer Res Treat. 2019 May 9. pii: 10.1007/s10549-019-05268.
    PubMed     Text format     Abstract available


    Breast J

  20. JORIS S, Fontaine C, Decoster L, Vanacker L, et al
    Retrospective comparison of two consecutive cohorts of adjuvant chemotherapy regimens of cyclophosphamide with either docetaxel or paclitaxel in older patients with early breast cancer.
    Breast J. 2019 May 9. doi: 10.1111/tbj.13306.
    PubMed     Text format     Abstract available

  21. ABDEL HADI M
    Breast cancer in developing countries: The shrinking age gap.
    Breast J. 2019 May 9. doi: 10.1111/tbj.13335.
    PubMed     Text format    

  22. PATEL A, Wang WJ, Warnack E, Joseph KA, et al
    Surgical treatment of young women with breast cancer: Public vs private hospitals.
    Breast J. 2019 May 9. doi: 10.1111/tbj.13294.
    PubMed     Text format     Abstract available


    Cancer Chemother Pharmacol

  23. CHEN X, Li C, Ewesuedo R, Yin D, et al
    Population pharmacokinetics of PF-05280014 (a trastuzumab biosimilar) and reference trastuzumab (Herceptin((R))) in patients with HER2-positive metastatic breast cancer.
    Cancer Chemother Pharmacol. 2019 May 3. pii: 10.1007/s00280-019-03850.
    PubMed     Text format     Abstract available


    Cancer Res

  24. BUCHTA ROSEAN C, Bostic RR, Ferey JCM, Feng TY, et al
    Pre-existing commensal dysbiosis is a host-intrinsic regulator of tissue inflammation and tumor cell dissemination in hormone receptor-positive breast cancer.
    Cancer Res. 2019 May 7. pii: 0008-5472.CAN-18-3464.
    PubMed     Text format     Abstract available


    Carcinogenesis

  25. PARK YY, Yun Jung S, Jennings NB, Rodriguez-Aguayo C, et al
    FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair.
    Carcinogenesis. 2019 May 7. pii: 5486539. doi: 10.1093.
    PubMed     Text format    


    Clin Breast Cancer

  26. SILVER E, Wenger N, Xie Z, Elashoff D, et al
    Implementing a Population-Based Breast Cancer Risk Assessment Program.
    Clin Breast Cancer. 2019 Mar 11. pii: S1526-8209(18)30761.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  27. FILIPITS M, Dubsky P, Rudas M, Greil R, et al
    Prediction of Distant Recurrence using EndoPredict among Women with ER+, HER2- Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy Only.
    Clin Cancer Res. 2019 May 7. pii: 1078-0432.CCR-19-0376.
    PubMed     Text format     Abstract available

  28. MOLINA-CRESPO A, Cadete A, Sarrio D, Gamez-Chiachio M, et al
    Intracellular delivery of an antibody targeting Gasdermin-B reduces HER2 breast cancer aggressiveness.
    Clin Cancer Res. 2019 May 7. pii: 1078-0432.CCR-18-2381.
    PubMed     Text format     Abstract available

  29. WAKS AG, Stover DG, Guerriero JL, Dillon DA, et al
    The immune microenvironment in hormone receptor-positive breast cancer before and after preoperative chemotherapy.
    Clin Cancer Res. 2019 May 6. pii: 1078-0432.CCR-19-0173.
    PubMed     Text format     Abstract available


    Clin Exp Metastasis

  30. LIU Y, Zheng H, Li Q, Li S, et al
    Discovery of CCL18 antagonist blocking breast cancer metastasis.
    Clin Exp Metastasis. 2019 May 6. pii: 10.1007/s10585-019-09965.
    PubMed     Text format     Abstract available

  31. ALZUBI MA, Sohal SS, Sriram M, Turner TH, et al
    Quantitative assessment of breast cancer liver metastasis expansion with patient-derived xenografts.
    Clin Exp Metastasis. 2019 May 8. pii: 10.1007/s10585-019-09968.
    PubMed     Text format     Abstract available


    Curr Treat Options Oncol

  32. LEE CHUY K, Yu AF
    Cardiotoxicity of Contemporary Breast Cancer Treatments.
    Curr Treat Options Oncol. 2019;20:51.
    PubMed     Text format     Abstract available


    Eur J Cancer

  33. MCCARTNEY A, Biagioni C, Schiavon G, Bergqvist M, et al
    Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor-positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT).
    Eur J Cancer. 2019;114:55-66.
    PubMed     Text format     Abstract available

  34. NOSKE A, Mobus V, Weber K, Schmatloch S, et al
    Relevance of tumour-infiltrating lymphocytes, PD-1 and PD-L1 in patients with high-risk, nodal-metastasised breast cancer of the German Adjuvant Intergroup Node-positive study.
    Eur J Cancer. 2019;114:76-88.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  35. DRAKE TM, Soreide K
    Cancer epigenetics in solid organ tumours: A primer for surgical oncologists.
    Eur J Surg Oncol. 2019;45:736-746.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  36. NAOUM GE, Salama L, Ho A, Horick NK, et al
    The Impact of Chest Wall Boost on Reconstruction Complications and Local Control in Patients Treated for Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2019 May 2. pii: S0360-3016(19)30659.
    PubMed     Text format     Abstract available


    J Clin Oncol

  37. EHRHARDT MJ, Howell CR, Hale K, Baassiri MJ, et al
    Subsequent Breast Cancer in Female Childhood Cancer Survivors in the St Jude Lifetime Cohort Study (SJLIFE).
    J Clin Oncol. 2019 May 10:JCO1801099. doi: 10.1200/JCO.18.01099.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  38. TESSIER L, Furzer J, Hodgson D, Cotton C, et al
    Cost-Utility of Early Breast Cancer Surveillance in Survivors of Thoracic Radiation-Treated Adolescent Hodgkin's Lymphoma.
    J Natl Cancer Inst. 2019 May 9. pii: 5485250. doi: 10.1093.
    PubMed     Text format     Abstract available


    N Engl J Med

  39. WALKER SP
    The ROC Curve Redefined - Optimizing Sensitivity (and Specificity) to the Lived Reality of Cancer.
    N Engl J Med. 2019;380:1594-1595.
    PubMed     Text format    


    Nat Rev Clin Oncol

  40. D'ABREO N, Adams S
    Immune-checkpoint inhibition for metastatic triple-negative breast cancer: safety first?
    Nat Rev Clin Oncol. 2019 May 3. pii: 10.1038/s41571-019-0216.
    PubMed     Text format    


    Oncogene

  41. HERNANDEZ-PEREZ S, Cabrera E, Salido E, Lim M, et al
    Correction: DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer.
    Oncogene. 2019 May 8. pii: 10.1038/s41388-019-0753.
    PubMed     Text format     Abstract available

  42. SORIA-VALLES C, Gutierrez-Fernandez A, Guiu M, Mari B, et al
    Correction: The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21.
    Oncogene. 2019 May 3. pii: 10.1038/s41388-019-0825.
    PubMed     Text format     Abstract available


    Oncol Rep

  43. WU M, Sun Q, Mo CH, Pang JS, et al
    Prospective molecular mechanism of COL5A1 in breast cancer based on a microarray, RNA sequencing and immunohistochemistry.
    Oncol Rep. 2019 May 3. doi: 10.3892/or.2019.7147.
    PubMed     Text format     Abstract available


    Oncology

  44. GUTH U, Elfgen C, Montagna G, Schmid SM, et al
    Long-Term Survival and Cure in Distant Metastatic Breast Cancer.
    Oncology. 2019 May 3:1-12. doi: 10.1159/000500298.
    PubMed     Text format     Abstract available


    PLoS One

  45. ZHAO Q, Howard EW, Parris AB, Ma Z, et al
    Bisphenol AF promotes estrogen receptor-positive breast cancer cell proliferation through amphiregulin-mediated crosstalk with receptor tyrosine kinase signaling.
    PLoS One. 2019;14:e0216469.
    PubMed     Text format     Abstract available

  46. UHR K, Prager-van der Smissen WJC, Heine AAJ, Ozturk B, et al
    MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines.
    PLoS One. 2019;14:e0216400.
    PubMed     Text format     Abstract available

  47. HUANG MH, Blackwood J, Godoshian M, Pfalzer L, et al
    Factors associated with self-reported falls, balance or walking difficulty in older survivors of breast, colorectal, lung, or prostate cancer: Results from Surveillance, Epidemiology, and End Results-Medicare Health Outcomes Survey linkage.
    PLoS One. 2018;13:e0208573.
    PubMed     Text format     Abstract available

  48. WITLOX L, Velthuis MJ, Boer JH, Steins Bisschop CN, et al
    Attendance and compliance with an exercise program during localized breast cancer treatment in a randomized controlled trial: The PACT study.
    PLoS One. 2019;14:e0215517.
    PubMed     Text format     Abstract available

  49. DIETEL E, Brobeil A, Delventhal L, Tag C, et al
    Crosstalks of the PTPIP51 interactome revealed in Her2 amplified breast cancer cells by the novel small molecule LDC3/Dynarrestin.
    PLoS One. 2019;14:e0216642.
    PubMed     Text format     Abstract available

  50. SALGUERO-ARANDA C, Sancho-Mensat D, Canals-Lorente B, Sultan S, et al
    STAT6 knockdown using multiple siRNA sequences inhibits proliferation and induces apoptosis of human colorectal and breast cancer cell lines.
    PLoS One. 2019;14:e0207558.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  51. JIA D, Lu M, Jung KH, Park JH, et al
    Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways.
    Proc Natl Acad Sci U S A. 2019;116:3909-3918.
    PubMed     Text format     Abstract available


    Radiology

  52. YALA A, Lehman C, Schuster T, Portnoi T, et al
    A Deep Learning Mammography-based Model for Improved Breast Cancer Risk Prediction.
    Radiology. 2019 May 7:182716. doi: 10.1148/radiol.2019182716.
    PubMed     Text format     Abstract available

  53. SIPPO DA, Burk KS, Mercaldo SF, Rutledge GM, et al
    Performance of Screening Breast MRI across Women with Different Elevated Breast Cancer Risk Indications.
    Radiology. 2019 May 7:181136. doi: 10.1148/radiol.2019181136.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: